| VISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML L Wang, B Jia, DF Claxton, WC Ehmann, WB Rybka, S Mineishi, S Naik, ... Oncoimmunology 7 (9), e1469594, 2018 | 116 | 2018 |
| Bone marrow CD8 T cells express high frequency of PD-1 and exhibit reduced anti-leukemia response in newly diagnosed AML patients B Jia, L Wang, DF Claxton, WC Ehmann, WB Rybka, S Mineishi, S Rizvi, ... Blood cancer journal 8 (3), 34, 2018 | 58 | 2018 |
| Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia L Zhu, Y Kong, J Zhang, DF Claxton, WC Ehmann, WB Rybka, ... Journal of Hematology & Oncology 10, 1-13, 2017 | 49 | 2017 |
| Eomes+T-betlow CD8+ T Cells Are Functionally Impaired and Are Associated with Poor Clinical Outcome in Patients with Acute Myeloid Leukemia B Jia, C Zhao, KL Rakszawski, DF Claxton, WC Ehmann, WB Rybka, ... Cancer research 79 (7), 1635-1645, 2019 | 47 | 2019 |
| Subtype-specific 3D genome alteration in acute myeloid leukaemia J Xu, F Song, H Lyu, M Kobayashi, B Zhang, Z Zhao, Y Hou, X Wang, ... Nature 611 (7935), 387-398, 2022 | 44 | 2022 |
| Downregulation of CD73 associates with T cell exhaustion in AML patients Y Kong, B Jia, C Zhao, DF Claxton, A Sharma, C Annageldiyev, JS Fotos, ... Journal of Hematology & Oncology 12 (1), 1-11, 2019 | 29 | 2019 |
| Effects of adoptive transferring different sources of myeloid-derived suppressor cells in mice corneal transplant survival Y He, B Wang, B Jia, J Guan, H Zeng, Z Pan Transplantation 99 (10), 2102-2108, 2015 | 25 | 2015 |
| Advanced NSCLC patients with high IL-6 levels have altered peripheral T cell population and signaling SJ Rice, X Liu, J Zhang, B Jia, H Zheng, CP Belani Lung Cancer 131, 58-61, 2019 | 23 | 2019 |
| The roles of sepsis-induced myeloid derived suppressor cells in mice corneal, skin and combined transplantation Y He, J Bei, H Zeng, Z Pan Transplant Immunology 34, 8-13, 2016 | 20 | 2016 |
| Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant C Zhao, M Bartock, B Jia, N Shah, DF Claxton, B Wirk, KL Rakszawski, ... Journal of Hematology & Oncology 15 (1), 1-7, 2022 | 18 | 2022 |
| A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia H Zheng, S Mineishi, D Claxton, J Zhu, C Zhao, B Jia, WC Ehmann, ... American Journal of Hematology 96 (2), E46, 2021 | 17 | 2021 |
| Multi‐dimensional analysis identifies an immune signature predicting response to decitabine treatment in elderly patients with AML C Zhao, B Jia, M Wang, TD Schell, DF Claxton, WC Ehmann, WB Rybka, ... British Journal of Haematology 188 (5), 674-684, 2020 | 12 | 2020 |
| Tumour-activated liver stromal cells regulate myeloid-derived suppressor cells accumulation in the liver H Zhang, G He, Y Kong, Y Chen, B Wang, X Sun, B Jia, X Xie, X Wang, ... Clinical & Experimental Immunology 188 (1), 96-108, 2017 | 11 | 2017 |
| A novel CD48-based analysis of sepsis-induced mouse myeloid-derived suppressor cell compartments B Jia, C Zhao, G Li, Y Kong, Y Ma, Q Wang, B Wang, H Zeng Mediators of Inflammation 2017, 2017 | 9 | 2017 |
| Protection of huanglian jiedu decoction on livers of hyperlipidemia mice YL Ma, T Li, BB Wang, B Jia, B Chen, J Su, XB Wang, H Zeng Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi Jiehe Zazhi= Chinese …, 2013 | 5 | 2013 |
| A novel clinically relevant graft-versus-leukemia model in humanized mice B Jia, C Zhao, M Bayerl, H Shike, DF Claxton, WC Ehmann, S Mineishi, ... Journal of leukocyte biology 111 (2), 427-437, 2022 | 4 | 2022 |
| TIGIT Expression Positively Associates with NK Cell Function in AML Patients B Jia, C Zhao, DF Claxton, WC Ehmann, WB Rybka, S Mineishi, S Naik, ... Blood 132, 5250, 2018 | 3 | 2018 |
| Avelumab in Combination with Eribulin Mesylate in Metastatic Urothelial Carcinoma: BTCRC GU-051, a Phase 1b Study M Joshi, SL Holder, J Zhu, H Zheng, S Komanduri, J Warrick, H Yasin, ... European urology focus 8 (2), 483-490, 2022 | 2 | 2022 |
| Effect of Avelumab to Immune Response in AML: A Phase I Study of Avelumab in Combination with Decitabine As First Line Treatment of Unfit Patients H Zheng, S Mineishi, DF Claxton, J Zhu, C Zhao, B Jia, WC Ehmann, ... Blood 134, 3939, 2019 | 2 | 2019 |
| CD26lowPD-1+ CD8 T cells are terminally exhausted and associated with leukemia progression in acute myeloid leukemia H Zhou, B Jia, C Annageldiyev, K Minagawa, C Zhao, S Mineishi, ... Frontiers in immunology 14, 2023 | 1 | 2023 |
